Orthobiologics

FzioMed received FDA approval to conduct a small confirmatory study of Oxiplex® synthetic viscoelastic gel, examining its use following lumbar surgery....

Anika Therapeutics received Australia regulatory approval to market MONOVISC® single-injection viscosupplement for the treatment of osteoarthritis pain in all synovial joints. ...

Vivorté launched FORTERA™ and REGENTO™ bone graft products for orthopaedic surgery....

FDA accepted DiscGenics’ Investigational New Drug Application for a clinical study of its cell therapy product candidate to treat degenerative disc disease....

CartiHeal enrolled and treated 16 patients in its IDE study of Agili-C™ implants in the treatment of joint surface lesions. ...

Subchondral Solutions received FDA 510(k) clearance to market the fenestrated, cannulated S4 Screw System™ to treat osteochondral fractures....

SpinalCyte was issued Australian Patent No. 2015202319, “Methods and Compositions for Repair of Cartilage Using an In Vivo Bioreactor.”...

Bone Therapeutics reports positive interim efficacy results and early conclusion of the Phase I/IIA study of ALLOB® allogeneic bone cell therapy in...

Bone Solutions commenced U.S. launch of OsteoCrete®, the first magnesium-based bone void filler in the U.S. ...

Follow-up data from an IDE clinical trial of Cerapedics’ i-FACTOR™ bone graft indicated statistical superiority to autograft in ACDF....